The Ngs Based Diagnostics Market is slated to grow on a stupendous note in the future. In the ongoing situation, virtual monitoring tools coupled with telehealth consultations could help in getting patients treatments at home instead of hospitals. There are pre-programmed mobile devices, pulse oximeters, blood pressure monitors, and various other devices that help the healthcare personnel in keeping up with basic information. This trend is bound to keep the healthcare vertical continuously on its toes in the years to come as well.
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms. They are unique from their earlier versions of first-generation dideoxy ‘Sanger’ sequencing and can perform parallel sequencing of several genomes simultaneously using a single instrument in less than two weeks.
Their sensitivity, high speed and less cost per sample make them a highly lucrative platform in comparison to others. Their main application would be early diagnosis of different types of cancers which occur due to genomic alterations such as mutations.
Apart from that they can be used to study the genome sequences of rapidly transforming drug resistant pathogenic bacteria. Diagnostic virology is another most successful advancement of NGS diagnostics that has discovered and characterized new viruses. Multiple sequencing platforms have been launched over last decade offering various sequencing approaches, such as whole genome sequencing (WGS), whole exome sequencing (WES) and amplicon sequencing.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/15784
Global next generation sequencing (NGS) based diagnostics market has been segmented on the basis of type of sequencing, application, end user and region.
Based on types of sequencing, the global next generation sequencing (NGS) based diagnostics market is segmented into:
- DNA Sequencing
- RNA Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Paired-End Sequencing
- Single Read Sequencing
- Multiplex Sequencing
- Deep Sequencing
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Based on the application, the next generation sequencing (NGS) based diagnostics market is segmented into:
- Cancer Diagnosis
- Connective Tissue Disorders Diagnosis
- Inborn errors of metabolism Diagnosis
- Neurodegenerative Diseases Diagnosis
- Fanconi Anaemia Diagnosis
- Lysosomal Storage Disorders Diagnosis
Based on the end user, next generation sequencing (NGS) based diagnostics market is segmented into the following:
- Hospitals
- Clinics
- Academics/Research Institutions
For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/15784
Global next generation sequencing (NGS) based diagnostics market has represented exponential growth as multiple new players have entered in this field with their platforms. Established players are reforming their technologies to compete with others. The market is highly fragmented due to presence of numerous players. Universities and other research organizations are significant contributors of this market.
Geographically, next generation sequencing (NGS) based diagnostics market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America is currently leading the market due to the research and innovations and presence of maximum numbers of players.
Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/15784
The key players in the global next generation sequencing (NGS) based diagnostics market include Janssen Global Services, LLC, F. Hoffmann La Roche Ltd., QIAGEN, Oxford Gene Technology, Illumina, Inc., ThermoFisher Scientific, Pacific Biosciences, Paradigm Diagnostics Inc., Innogene Kalbiotech, Admera Health, AITbiotech Pte Ltd, CENTOGENE AG, Phalanx Biotech Group, iGenomX.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com